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ABSTRACT Calcium is an essential ion serving a
multitude of physiological roles. Aside from its role as
a second messenger, it is an essential component of the
vertebrate bone matrix. Efficient uptake and storage of
calcium are therefore indispensable for all vertebrates.
Transient receptor potential family, vanilloid type
(TRPV)5 and TRPV6 channels are known players in
transcellular calcium uptake, but the exact contribution
of this pathway is unclear. We used forward genetic
screening in zebrafish (Danio rerio) to identify genes
essential in bone formation and identified a lethal
zebrafish mutant (matt-und-schlapp) with severe defects
in bone formation, including lack of ossification of the
vertebral column and craniofacial structures. Mutant
embryos show a 68% reduction in calcium content, and
systemic calcium homeostasis is disturbed when com-
pared with siblings. The phenotype can be partially
rescued by increasing ambient calcium levels to 25 mM.
We identified the mutation as a loss-of-function muta-
tion in the single orthologue of TRPV5 and 6, trpv5/6.
Expression in HEK293 cells showed that Trpv5/6 is a
calcium-selective channel capable of inward calcium
transport at physiological concentrations whereas the
mutant channel is not. Taken together, this study
provides both genetic and functional evidence that
transcellular epithelial calcium uptake is vital to sustain
life and enable bone formation.—Vanoevelen, J., Jans-
sens, A., Huitema, L. F. A., Hammond, C. L., Metz,
J. R., Flik, G., Voets, T., Schulte-Merker, S. Trpv5/6 is
vital for epithelial calcium uptake and bone formation.
FASEB J. 25, 000–000 (2011). www.fasebj.org
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Calcium (Ca2) is an essential ion that serves many
physiological roles, both extra- and intracellularly.
Carefully controlled intracellular Ca2 concentrations
are therefore indispensable to fulfill a range of biolog-
ical functions, including muscle contraction, synaptic
transmission, cell death, and many more (1, 2). In
vertebrates, bone serves as an important Ca2 store for
systemic homeostasis, and plasma Ca2 is in equilib-
rium with Ca2-hydroxyapatites in the bone matrix (3).
Since such a wide variety of processes depend on the
availability of Ca2, it is crucial that sufficient amounts
of Ca2 are taken up and the Ca2 levels in body fluids
are kept within a narrow concentration range (2–3 mM;
ref. 4).
Terrestrial vertebrates acquire sufficient Ca2 from
ingested food, and the intestine therefore is the main
site of uptake. There exist 2 Ca2 uptake pathways: an
energy-dependent transcellular pathway and a passive
paracellular pathway (5). In the transcellular pathway,
Ca2 enters the enterocytes through the apical mem-
brane via a Ca2-permeable channel of the transient
receptor potential family, vanilloid type (TRPV)6 (6).
In the cytosol of the enterocyte, Ca2 ions are readily
complexed to Ca2-buffering proteins like calbindin-
D9K (7). At the basal side of the epithelium, Ca
2 is
actively extruded via plasma membrane Ca2-ATPase 1
(PMCA1; ref. 8) and Na/Ca2 exchanger 1 (NCX1;
ref. 9) and thus enters the blood and can be trans-
ported throughout the body. In addition, there exists a
renal reabsorption pathway in which Ca2 is taken up
from the forming urine. Initial uptake in the kidney
tubules occurs via TRPV5 (10), and basolateral trans-
port is also achieved through NCX1 and PMCA1 (11).
The paracellular route involves passive diffusion and
mainly depends on Ca2 concentration gradients and
the tightness of the epithelium (12, 13). The molecular
principles for transepithelial Ca2 transport are highly
conserved between fish and mammals (14), although
their habitat is different; ambient water provides a
sufficient source of Ca2 (seawater: 10 mM; freshwater:
0.025–3.0 mM). In fish, Ca2 is taken up mainly
(97%) by the gills, and chloride cells have long been
recognized as the main cell type involved in this process
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(4, 15). These cells contain all molecular components
(Trpv5/6, Pmcas, and Nxc-homologues) that are
thought to play a role in transepithelial Ca2 uptake
(16), although their contribution has never been stud-
ied at the molecular level.
The transient receptor potential (TRP) family is a
large protein family consisting of several subfamilies, of
which the TRPV is an example. The TRPV family can be
divided into 4 groups: TRPV1/2, TRPV3, TRPV4, and
TRPV5/6 (reviewed in ref. 17). TRPV1–TRPV4 are
nonselective cation channels that can be activated by a
number of different stimuli, such as second-messenger
binding, heat and cold, and chemical and/or mechan-
ical stress (18, 19). These channels are modestly per-
meable for Ca2, whereas the other 2 members of the
family, TRPV5 and TRPV6, are highly selective for Ca2
and tightly regulated by intracellular Ca2 concentra-
tion (20–22).
An important question remaining in the field of
epithelial Ca2 transport concerns the exact contribu-
tion of the transcellular vs. the paracellular pathway
(23, 24). Mouse single-knockout models for compo-
nents of the transcellular pathway, Trpv5 and Trpv6,
failed to answer this question due to functional redun-
dancy and compensatory mechanisms by other genes
and pathways regulating Ca2 homeostasis, including
parathyroid hormone- and vitamin D-dependent mech-
anisms (25, 26).
The vertebrate body contains a large pool of immo-
bilized Ca2 in the skeleton. Besides its role in Ca2
storage, bones are important in supporting the verte-
brate body, enabling movement by providing a matrix
for the attachment of muscles and tendons and protec-
tion of important organs like the brain and heart (27).
Skeletal homeostasis is established by balancing bone
formation through the activity of osteoblasts and
through bone resorption by osteoclasts, processes that
exhibit a large extent of evolutionary conservation
between fish and mammals (28). We used forward
genetic screening in zebrafish to identify genes criti-
cally involved in bone formation and identified the
single orthologue of mammalian TRPV5/6 as a main
regulator of bone formation and transepithelial Ca2
uptake, establishing an in vivo model for this essential
physiological process.
MATERIALS AND METHODS
Screening procedure
Forward genetic screening was performed as described by
Spoorendonk et al. (29).
Molecular biology
The cDNA encoding trpv5/6 was amplified from reverse-
transcribed RNA and ligated into a pGEM-T easy (Promega,
Madison, WI, USA) cloning vector. For expression in HEK293
cells, the ends of the cDNA were modified with appropriate
restriction sites using PCR and ligated into the pCINeo/IRES-
GFP vector.
Meiotic mapping
The matt-und-schlapp mutation was mapped to linkage group 16
using standard simple sequence length polymorphism (SSLP)
mapping. Fine mapping was performed using custom repeat
markers and single-nucleotide polymorphisms (SNPs). Primer
sequences are as follows: Rep12For 5-TGGAGATTACTGTAG-
GTCAGAACA-3, Rep12Rev 5-CTGTGAAAATTGCCTTGCTC-
3; SNPAFor 5-CCATCACTGGTGTTTTGGACT-3, SNPARev
5-TGAAGGAAAGCTGGTCATTTG-3; and SNPBFor 5-TTCTA-
GTGTGGACGGTGCAA-3, SNPBRev 5-CACCACGTTCTTGTA-
ATGTCA-3.
Skeletal staining
The protocol for bone and cartilage staining was adapted
from Walker and Kimmel (30). Embryos were fixed in 3.5%
formaldehyde and stored in 70% methanol at 4°C until
further use. Embryos were partially dehydrated in 50% etha-
nol and stained with 0.2 mg/ml Alcian blue 8 GX (Sigma, St.
Louis, MO, USA) in 70% ethanol containing 80 mM MgCl2.
Next, embryos were bleached in 1% H2O2/1% KOH for 30
min, washed in a saturated sodium tetraborate solution, and
digested for 1 h in 1 mg/ml trypsin (Sigma) in 60% sodi-
umtetraborate. Bone was stained with 0.04 mg/ml Alizarin
red S (Sigma) in 1% KOH. Finally, specimens were dehy-
drated to 70% glycerol and stored at 4°C.
In situ hybridization
In situ hybridization was performed essentially as described
previously (31, 32). Briefly, embryos were fixed in 4% para-
formaldehyde in PBS, transferred to methanol, and rehy-
drated. Embryos were permeablilzed by proteinase-K treat-
ment in PBS  0.1% Tween 20 (PBST). Embryos were
prehybridized for 2 h at 68°C before overnight hybridization
at 68°C in hybridization solution (50% formamide 5 SSC,
500 mg/ml yeast tRNA, 50 mg/ml heparin, 0.2% Tween 20,
and 9.2 mM citric acid) containing digoxygenin-labeled anti-
sense probes. Embryos were then washed in 2 SSCT (300
mM NaCl, 15 mM sodium citrate, and 0.1% Tween 20) and
taken to 0.2 SSCT at 68°C. After graded changes to PBS,
embryos were blocked for 2 h with Roche blocking reagent
(Roche, Indianapolis, IN, USA) in PBS at 4°C and subse-
quently incubated overnight with blocking reagent contain-
ing antidioxygenin antibodies labeled with alkaline phospha-
tase (Roche), diluted in blocking buffer. After being washed 6 times
in PBST, embryos were transferred to alkaline phosphate buffer
(100 mM Tris, 50 mM MgCl2, 100 mM NaCl, and 0.1% Tween 20),
and staining was developed using nitroblue tetrazolium/5-bromo-
4-chloro-3-indolyl phosphate. Primer sequences used to generate in
situ probes were as follows: trpv5/6-5probeFor 5-GGGATGG-
AATGAAATGTTGG-3, trpv5/6-5probeRev 5-GTGTTCATCGAC-
CCTGGAGT-3; Stc-1.2For 5-GCAAACATCTCCTGCTTTGG-3,
Stc-1.2Rev 5-TCGATATCCTGCACACTTGC-3; Ron2For 5-GT-
CTTCCGCATTGGACACTT-3, Ron2Rev 5-GCCGAGTCTTGTC-
TGAAAGG-3; col1a2-5ProbeFor 5-AAGGACTGCAAGGACAT-
GCT-3, col1a2-5ProbeRev 5-TGCTCTCCAGTTGACCCTCT-3;
col10a1-5ProbeFor 5-TGCCCATGGTGAGAGATATG-3, col10a1-
5ProbeRev 5-GCATACCAGGAGCACCATTC-3; and sparcProbe-
For 5-TGAGGGTTTGGATCTTCTTCC-3, sparcProbeRev 5-
TGTCGACATCCTGCTCTTTG-3. In situ hybridizations were
performed at least 2 times, and embryos were genotyped afterward.
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Genotyping
Genomic DNA of single embryos was extracted and subjected to
KASPar SNP genotyping (KBiosciences, Hoddesdon, UK) using
protocols described by the manufacturer. Primer sequences
are as follows: ForwardSib 5-GAAGGTGACCAAGTTC-
ATGCTGTGATTTGTTTGTCTCAGGCCAGAA-3, ForwardMut
5-GAAGGTCGGAGTCAACGGATTGTGATTTGTTTGTCT-
CAGGCCAGAT-3, and CommonReverse 5-GATGAGCT-
GTCGGACTGGAGTCAA-3.
Ca2 and phosphorous measurements
Mutant and sibling embryos were phenotyped and overanes-
thetized using MS-222, washed twice with deionized water,
and dried overnight under vacuum. Ions were released with
60% nitric acid. Next, samples were diluted using deionized
water and measured using atomic absorption spectrophotom-
etry (Solaar; Thermo Elemental, Winsford, UK; ref. 33).
Statistical significance was determined using Student’s t test.
Microscopy
In situ hybridizations were analyzed on a Zeiss Axioplan
microscope (Carl Zeiss, Go¨ttingen, Germany) equipped with
a Leica 480C camera (Leica, Wetzlar, Germany). For analyses
in transgenic backgrounds, embryos were stained in vivo for
bone with 0.05% Alizarin red, washed with E3 medium,
anesthetized with MS-222, and embedded in 0.5% agarose.
Images were captured on a Leica TCS-SPE confocal micro-
scope. Intracellular Ca2-imaging was performed using a
CellM system (Olympus, Hamburg, Germany).
Transgenic lines
The osx:nuGFP line was generated as follows: the 4.1-kb
upstream regulatory region of the medaka osterix gene was
amplified (34) and cloned in front of a nuclear localization
signal followed by GFP (nuGFP). Transgenic zebrafish were
generated using the Tol2 transposon system (35). An osc:GFP
reporter line was generated by amplification of a 3.5-kb
upstream regulatory region of the medaka osteocalcin gene
and cloned in front of GFP (36).
Evaluation of heart rates
Embryos of 54 hours postfertilization (hpf) were anesthetized
using MS-222 and transferred to 24-well plates and left to
acclimatize for 30 min. Heart rates were counted over inter-
vals of 20 s, and each embryo was evaluated 3 times before
genotyping.
Cell culture and transfections
HEK-293 cells were grown in DMEM medium containing 10%
(v/v) fetal calf serum, 2 mM l-glutamine, 2 U/ml penicillin,
and 2 mg/ml streptomycin at 37°C in an incubator with 10%
CO2. They were transfected with the pCINeo/IRES-GFP/
trpv5/6 vector using TransIT-293 transfection reagent (Mirus,
Madison, WI, USA), and electrophysiological recordings were
performed 24 h later.
Intracellular Ca2-imaging
Transfected cells were incubated with 2 M fura-2 acetoxy-
methyl ester for 30 min at 37°C. Intracellular Ca2 concen-
tration was monitored via the ratio of fluorescence measured
on alternating illumination at 354 and 380 nm using an
MT-10 illumination system and CellM software (Olympus).
Electrophysiology
Transfected cells were identified by their green fluorescence.
Patch-clamp experiments were performed in the tight-seal
whole-cell configuration using an EPC-9 patch-clamp ampli-
fier and Pulse software (HEKA Electronics, Lambrecht, Ger-
many). Patch pipettes had DC resistances of 2–4 M when
filled with intracellular solution (150 mM NaCl, 5 mM MgCl2,
5 mM EGTA, and 10 mM HEPES, pH 7.4). Series resistances
were between 3 and 10 M and were compensated 60–80%.
Currents were sampled at 10 kHz and filtered at 2.9 kHz using
an 8-pole Bessel filter. The stimulation protocol consisted of
a linear voltage ramp from 50 to 100 mV (in 400 ms),
which was applied every 5 s. The divalent cation-free extra-
cellular solutions contained 150 mM XCl [where X  Na,
K, or N-methyl-d-glucamine (NMDG)] and 10 mM HEPES,
titrated to pH 7.4 with XOH. Isotonic divalent cation solu-
tions contained 100 mM XCl2 (where X Ca, Ba, or Mg) and
10 mM HEPES, titrated to pH 7.4 with X(OH)2. For the
anomalous mole fraction behavior, NaCl and CaCl2 solutions
were mixed. All experiments were performed at room tem-
perature (20–22°C).
Ca2 enrichment and depletion
Embryos were collected and transferred to modified E3
medium (5 mM NaCl, 0.17 mM KCl, and 0.33 mM MgSO4;
ref. 37) supplemented with the indicated amounts of total
Ca2 and incubated at 28,5°C. Embryos were fixed at 7 days
postfertilization (dpf) and processed for cartilage and bone
staining.
RESULTS
Matt-und-schlapp phenotype
Matt-und-schlapp (German for “slack as a rag”) embryos
completely lack ossification of the axial skeleton
(Fig. 1A). They fail to inflate their swim bladder and die
at 7–9 dpf. Analysis of the phenotype at 7 dpf revealed
some phenotypic variability in terms of ossification
(Fig. 1A). Mutants were scored as mild when they
lacked ossification of the axial skeleton but possessed
some normally ossified craniofacial elements such as
cleithrum, opercle, parasphenoid, and the teeth on the
fifth branchial arch. Mineralization of the teeth was
reduced in the mild phenotype. Mutants were catego-
rized as severe when all ossification was absent, except
for the otoliths. Bright field images (Fig. 1A, insets) of
the mutant embryos illustrate that the tip of the noto-
chord is formed correctly, but ossification is absent.
Otoliths (which are mineralized, nonbone structures)
are present but remain smaller in size. All cartilage
elements are present and indistinguishable between
siblings and mutants.
Matt-und-schlapp encodes trpv5/6
Genome scan analysis linked the mutation to linkage
group (LG) 16 (Fig. 1B). With the use of standard
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SSLP mapping, the region of interest was reduced to
1 Mb using custom repeat markers. Finally, by iden-
tification of informative SNPs, the region was further
reduced to an interval of 50 kb containing a single
gene: trpv5/6, a member of the TRPV family (Fig.
1B). Sequencing of the trpv5/6-encoding cDNA in
siblings and mutants revealed a single A to T nucleo-
tide change resulting in a premature stop codon at
position 304 (R304Stop) of the predicted protein
(Fig. 1C).
Figure 1. Phenotypic description and mapping of mus. A) Bone (red) and cartilage (blue) staining of sibling and mutant
embryos at 7 dpf. Top panels: ventral view of sibling, mild mutant, and severe mutant phenotypes, respectively. Bottom left and
middle panels: embryos in side view. Bottom right panels: detail of the tip of the notochord. Key skeletal elements are indicated:
ps, parasphenoid; op, opercle; th, teeth; oto, otoliths; tn, tip of the notochord; cl, cleithrum; cen, vertebral centrum. Scale bars
100 m. B) Overview of meiotic mapping strategy. Numbers indicate number of recombinants/number of mutant embryos and
the genomic location (in Mb) according to the Ensemble zebrafish genome browser (Zv9). Markers Rep12 and Rep21 are
flanking markers restricting the critical region to 2 Mb. This region was narrowed further by single-embryo mapping using
SNP markers. Markers Rep12 and SNPA demarcate a region of interest containing only 1 gene: trpv5/6. C) Sequencing of
mutant and heterozygous cDNA. Causative mutation is identified as an A to T substitution resulting in an amino acid change
of arginine (R) to a premature stop codon (R304Stop). D) Top: schematic depiction of the wild-type Trpv5/6 protein with
putative functional domains indicated. Bottom position of the mutation resulting in a premature stop codon. E) Synteny of
chromosome regions at the position of trpv5/6 between zebrafish and human chromosomes. Numbers (Mb) represent the
chromosomal positions of the respective genes. The order of a number of genes in the region is conserved between zebrafish
LG16 and parts of human chromosome 7 and 12. Note the absence of a second isoform of trpv5/6 in zebrafish. F) Phylogenetic
analysis of TRPV5/6 genes in mammals: Homo sapiens (Hs) and Mus musculus (Mm); birds: Gallus gallus (Gg); amphibians:
Xenopus laevis (Xl); and fish: Takifugu rubripes (Tr) and Danio rerio (Dr). Only mammals show 2 distinct TRPV5/6-genes;
amphibians and fish genomes only contain 1 trpv5/6 gene. Phylogenetic tree (guide tree) was constructed using the
neighbor-joining method in Vector NTI (Invitrogen) and visualized using TreeView software.
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Characterization of trpv5/6
The trpv5/6 gene is composed of 18 exons spanning 31
kb on LG16. The mutation must25927 is located in exon
9. The resulting wild-type protein consists of 709 aa with
a predicted molecular mass of 81.1 kDa (Fig. 1D). The
mutated protein R304Stop results in a severely trun-
cated protein containing only 303 of the predicted 709
aa and is lacking all putative transmembrane domains
including the pore region (Fig. 1D). Mammalian ge-
nomes contain 2 genes coding for epithelial calcium
channels (ECaCs), which were initially termed ECaC1
(or CaT2; ref. 10) and ECaC2 (CaT1; ref. 6) and later
renamed TRPV5 and TRPV6, respectively. The ze-
brafish, amphibian, and avian genomes contain only
one ECaC isoform (trpv5/6; Fig. 1E, F). Figure 1E shows
a large degree of synteny in the region of trpv5/6 on
LG16 of the zebrafish genome and chromosomes 12
and 7 of the human genome and illustrates the juxta-
posed location of TRPV5 and TRPV6 in the human
genome. No second homologue could be detected in
zebrafish. Phylogenetic analysis further shows that
mammalian TRPV5 and TRPV6 do not cluster together
in the same groups, nor do the nonmammlian iso-
forms. This notion and the adjacent position of TRPV5
and TRPV6 on the same chromosome in mammals
support the notion of a gene duplication event in
mammals that occurred after the divergence of mam-
malian and other vertebrate Trpv5/6, which is in line
with other phylogenetic studies comparing mammalian
isoforms to other vertebrate species (38).
Trpv5/6 mRNA expression was first observed at 24
hpf in the epithelial layer covering the yolk sac and yolk
extension (Fig. 2C). At later stages (4 dpf), expression
was still present in the skin, but highest expression
levels were in the branchial region where the gills will
form (Fig. 2B). In mutant embryos, trpv5/6 expression
was absent at 24 hpf (Fig. 2B) and severely reduced at
later stages (4 dpf) when compared with siblings (Fig.
2C). Under standard rearing conditions (0.33 mM total
Ca2 in the E3 embryo medium; ref. 37), 25% of the
embryos from a heterozygous parental pair showed
the phenotype, as predicted for a recessive mutation
(Fig. 2A).
Mutants have very low Ca2 content and can be
rescued by extracellular Ca2
Since mammalian TRPV5 and TRPV6 are Ca2-selec-
tive channels involved in active Ca2 reabsorption, we
investigated the overall Ca2 content in mutant vs.
sibling embryos by atomic absorption spectrometry.
Mutant embryos showed a reduction in Ca2 content of
68% (8695 vs. 2732 ppb/mg protein; P	0.05) when
compared with siblings (Fig. 3A). We also measured the
phosphorous content of the same samples (Fig. 3B).
Here, the difference was much smaller and not statisti-
cally significant (18%; 13,620 vs. 11,204 ppb/mg pro-
tein) but in line with the observed reduction of miner-
alized bone in the mutant embryos (Fig. 1A). To
further test whether the mutants displayed systemic
Ca2 deficiency, we investigated the expression of
stanniocalcin 1 (stc1), an antihypercalcaemic hormone
secreted by the corpuscles of Stannius (39, 40), fish-
specific endocrine organs involved in Ca2 metabolism
(40, 41). Stc1 expression was completely absent in
mutant embryos (Fig. 3C) even though the corpuscules
of Stannius were correctly formed, as indicated by ron2
expression. Ron2 is a tyrosine-receptor kinase expressed
in the corpuscules of Stannius and pronephric ducts
(Fig. 3D). As the reduced whole-body Ca2 content was
suggestive of a defect in Ca2 uptake, we exposed
mutant embryos to different concentrations of extracel-
lular Ca2, ranging from a minimal (nominally 10 M
total Ca2) or a standard amount (0.33 mM total Ca2)
to a very high amount (25 mM total Ca2; Fig. 2A).
Under conditions of low-Ca2 availability (10 M), a
mortality rate corresponding to the predicted frac-
tion of mutant embryos (25%) was observed. This
shows that mutant embryos are hypersensitive to low
Ca2 availability. Under conditions of normal Ca2
(0.33 mM; the concentration used under standard
Figure 2. Phenotype dependence on Ca2 and expression pattern. A) Distribution of the phenotypes in embryos grown in
different extracellular Ca2 concentrations. Same classification of mild and severe phenotypes as in Fig. 1A is used here. In
standard growing conditions, the total extracellular Ca2 concentration is 0.33 mM. Stacked bars represent the percentage of
phenotypes from a total of 150 embryos/condition from 3 independent experiments. B, C) trpv5/6 mRNA expression pattern
in sibling and mutant embryos using in situ hybridization at 24 hpf (B) and at 4 dpf (C).
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rearing conditions), the predicted fraction of mutant
phenotypes (25%) was observed with an equal
distribution between mild and severe phenotypes
(Fig. 2A). At 25 mM Ca2, no mutant phenotypes
were observed (Fig. 2A) but lethality past 7–9 dpf
could not be overcome. Taken together, these results
Figure 3. Ca2 deficiency and disturbed Ca2 homeostasis in mus
mutants. A) Quantification of Ca2 content in mutant and sibling
embryos at 6 dpf using atomic absorption spectrometry. Mutants
contain significantly (P	0.05) less Ca2when compared with siblings.
Measurements are average values of 3 independent experiments
measuring a total of 19 single embryos/condition. B) Determination
of phosphorous content, as a measure for the amount of phosphate,
at 6 dpf in sibling and mutant embryos using atomic absorption
spectrometry. Phosphorous content is only modestly lower (not signif-
icant) in mutants. This difference is attributed to the presence of less
bone in the mutants. Same samples as in A were used. C) Expression
of stanniocalcin 1 (stc1) in embryos at 4 dpf using in situ hybridization.
Insets: detailed view of expression in the corpuscules of Stannius. Scale
bars 100m. D) Expression of ron2 in embryos at 4 dpf. Expression
of ron2 is present in both siblings and mutants indicating that the
corpuscules of Stannius are formed correctly despite lacking stc1
expression. Scale bar  100 m. E) Heart rates in a clutch of mus
embryos. Average heart rates were counted in 48 anesthetized
embryos at 54 hpf. Each embryo was evaluated 3 times before
genotyping; n  number of embryos of each genotype that
were evaluated. Statistical significance was determined using a Student’s t test. Values are depicted as average 
 sd.
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show that mutant embryos are hypersensitive to
low-Ca2 availability and can be rescued by high Ca2
concentrations in the medium, indicating defects in
Ca2 uptake. We also tested whether other Ca2-
dependent physiological processes are affected in
mus mutants. Heart contraction was evaluated, and
no difference between genotypes could be observed
(Fig. 3E). Mutant embryos also still exhibited a touch
response, indicating that skeletal muscles and the
sensory system were functional. To address the ques-
tion of whether the observed bone phenotypes are
specifically due to nonfunctional Trpv5/6 channels
or an effect secondary to Ca2 deficiency, we re-
peated rearing wild-type embryos in different Ca2
concentrations (Supplemental Fig. S1). When nor-
mal embryos were grown in low amounts (5 and 10
M added Ca2) of extracellular Ca2, the same
bone phenotypes were observed (Supplemental Fig.
S1). Stc1 expression in wild-type embryos grown in
low Ca2 was also severely reduced (Supplemental
Fig. S1C). Thus, the bone phenotype of mus embryos
can be phenocopied in wild-type embryos by severe-
ly restricting the extracellular Ca2 concentration.
Taken together, these data support the notion that
mus mutant embryos suffer from Ca2 deficiency,
which is primarily reflected by the absence of ossifi-
cation of the axial skeleton, whereas other functions
that highly depend on Ca2 appear normal at least
until d 7.
Mineralization is impaired in mus mutants while
differentiated osteoblasts are present
To uncover whether the lack of ossification in mutant
embryos was due to general Ca2 deficiency or to a lack
of osteoblast differentiation, we crossed the mus allele
into transgenic reporter lines marking early (osx:
nuGFP; ref. 34) and mature (osc:GFP) osteoblasts (36)
respectively. Osterix expression in mutant embryos was
indistinguishable from that in sibling embryos and
corresponded to the ossified structures, as visualized by
Alizarin red staining (Fig. 4A). Significantly, there was
an absence of ossification of the tip of the notochord
and the forming vertebrae in mutants, a hallmark of
the mutant phenotype. As expected, the number of
differentiated (osc-positive) osteoblasts was less than the
amount of undifferentiated (osx-positive) osteoblasts,
since osteoblast development is still in progress at this
stage. Osterix espression indicates that spatially and
temporally development of early osteoblasts takes place
in mus mutants. Osteocalcin expression, however, was
absent in mus mutant embryos (Fig. 4B). To show
whether this lack of osteocalcin expression was due to
lack of osteoblast differentiation or to dependence of
osteocalcin expression on Ca2 availability, we explored
the expression of other late osteoblast markers (col1a2,
col10a1) using in situ hybridization (Fig. 4C). The
expression patterns of both col1a2 and col10a1 were
indistinguishable between siblings and mutant em-
Figure 4. Osteoblast differentiation does occur in mus
mutant embryos. Confocal imaging of transgenic osteoblast
reporter lines in live zebrafish. A, B) Side view of sibling
(top panels) and mus embryos (bottom panels) at 6 dpf.
Green channel shows osx:nuGFP expression; red channel
marks the ossified matrix stained with Alizarin red.
A) Osterix expression in siblings and mus mutants is compa-
rable, indicating the presence of early osteoblasts at sites of
ossification in the craniofacial skeleton. Right panel shows
an overlay of the fluorescence images with the bright field
image. Insets: magnified view of the opercle. B) Osteocalcin is
expressed in siblings in the cleithrum and opercle, sites
where mineralization is first detected. In mus mutants, no
osteocalcin expression is observed. Images are maximal pro-
jections from a series of confocal stacks of each embryo. At least 4 embryos/genotype were analyzed in at least 2 separate
experiments. C) Expression of additional late osteoblast markers in sibling and mus embryos at 4 dpf. Two markers of
differentiated osteoblasts, col1a2 and col10a1, were examined using in situ hybridization. Col1a2 and col10a1 expression is
shown at the cleithrum, opercle, parasphenoid, teeth on the 5th branchial arch, and lower jaw, which are the first elements
to be mineralized. Insets: details of the opercle showing col1a2 expression. No differences between sibling and mus embryos
were detected. Expression patterns of 20–30 embryos of a single clutch were analyzed; embryos used for imaging were
subsequently genotyped. Scale bars  100 m.
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bryos; the elements that are first to mineralize showed
the presence of differentiated osteoblasts: cleitrum,
opercle, teeth on the fifth branchial arch, parasphe-
noid, and Meckel’s cartilage. The expression pattern of
an additional late osteoblast marker, sparc (osteonectin),
also showed no difference in expression in mutant vs.
sibling embryos (Supplemental Fig. S3). Since only the
osteocalcin expression pattern was altered in the mutant
embryos, we concluded that mature osteoblasts exist in
mus mutant embryos and that osteocalcin expression is
dependent on the availability of sufficient Ca2, while
expression of other markers is not.
Trpv5/6 is a Ca2-selective cation channel
To investigate the characteristics of Trpv5/6, wild-type
Trpv5/6 was expressed in HEK293 cells, a well-estab-
lished overexpression host, and ion currents were re-
corded in whole-cell patch-clamp experiments. In diva-
lent cation-free conditions with Na or K (150 mM) as
the sole extracellular cation, we measured strongly
inwardly rectifying currents that reversed around 0 mV,
whereas no inward current could be measured when
the large cation NMDG was the only extracellular
cation (Fig. 5A). These data indicate that Trpv5/6 is an
inwardly rectifying cation channel, permeable to Na
and K. In isotonic CaCl2 solution (100 mM), the
reversal potential shifted toward positive potentials,
indicative of a Ca2-selective current (Fig. 5B). From
the reversal potential of 56 
 7 mV, we calculated a
relative permeability (PCa/PNa) of 120 
 13. We also
measured significant permeability for Ba2 (PBa/
PNa38
13), whereas no inward currents could be
measured with Mg2 as the sole charge carrier (Fig.
5B). Increasing extracellular Ca2 from 1 M to 100
mM revealed anomalous mole fraction behavior (Fig.
5C). This is a hallmark of highly Ca2-selective chan-
nels and reflects inhibition of inward Na current at
low Ca2 concentrations and Ca2 permeation at
higher concentrations. Taken together, these results
demonstrate that Trpv5/6 is a Ca2-selective channel,
analogous to mammalian isoforms. Whereas mamma-
lian TRPV5 and TRPV6 are similar in their biophysical
properties, they differ in their sensitivity to block by
ruthenium red (RR). We found that the RR sensitivity
of Trpv5/6 was more comparable with that of mamma-
lian TRPV6, with only partial inhibition at 10 M and
an IC50 value of 4 M (Fig. 5D, E). To directly show
whether the channel resulting from the mus mutation
was functional, we also expressed the mutant channel
and ion currents were measured. Almost no current was
observed in the presence of Na (Supplemental Fig.
S2A) or Ca2 (Supplemental Fig. S2B) in the mutant
channel, whereas the wild-type channel was an inwardly
rectifying, Ca2-selective channel (Supplemental Fig.
S2A, B). Quantification of the amount of current at
100 mV in the presence of Na or Ca2 is shown in
Supplemental Fig. S2C, D. These results confirm that
the mutation is a loss-of-function mutation, as pre-
dicted from the position of the mutation early in the
coding sequence.
We also performed cytosolic Ca2 measurements to
directly show inward Ca2 transport from the extracellu-
lar space to the cytosol via Trpv5/6 (Fig. 6). A concentra-
tion-dependent cytosolic response of Ca2 on addition of
increasing amounts of extracellular Ca2 was observed
(Fig. 6). Note that a large cytosolic response was already
observed at concentrations 	0.33 mM Ca2, correspond-
ing to the concentration used in normal E3 medium. This
supports the view that Trpv5/6 is capable of epithelial
Ca2 uptake under physiological growth conditions.
DISCUSSION
The phenotype was termed matt-und-schlapp, referring
to the loss of rigidity in the absence of an ossified
vertebral column. The expression pattern of trpv5/6
confirms the results of previous studies showing that
expression in zebrafish commences at 24 hpf and
becomes restricted to the skin and gill area (4). With
the use of RT-PCR, however, expression of trpv5/6 was
shown in all tissues tested, with highest levels in gill,
intestine, and kidney (4). In addition, these researchers
showed that the number of trpv5/6-expressing cells is
dependent on the extracellular Ca2 concentration
(4). Gill expression has also been shown for trpv5/6 of
other fish species (38). We show that levels of mRNA
Figure 5. Trpv5/6 is a calcium-selective cation channel. Whole-cell patch-clamp experiments on Trpv5/6-overexpressing
HEK293 cells. A) Current-voltage (I-V) relations when using Na (black trace), K (green trace), or NMDG (red trace) as the
sole cation in the extracellular solution. B) Comparison of current-voltage relations obtained with Na, Ba2, Ca2, or Mg2
as the sole extracellular cation. C) Anomalous mole fraction behavior when extracellular Ca2 is increased from 1 M to 100
mM. D) Current-voltage relations showing partial block of Trpv5/6 currents in the presence of 10 M RR. E) Dose-response
curve for the inhibition of Trpv5/6 by RR.
8 Vol. 25 September 2011 VANOEVELEN ET AL.The FASEB Journal  www.fasebj.org
expression differ between siblings vs. mutants. At 24
hpf, there is no detectable trpv5/6 expression in the
mutants, while at 4 dpf, there is markedly less trpv5/6
expression in mutant embryos, suggesting degradation
of the mutant mRNA by nonsense-mediated decay (42).
The lack of stc1 expression is not surprising, since stc1
mRNA levels are regulated by extracellular Ca2, and,
in turn, trpv5/6 expression is down-regulated when
Ca2 is present in sufficient amounts (40). Incubation
of embryos in low Ca2-containing medium resulted in
up-regulation of trpv5/6 and down-regulation of stc1
(40), indicative of a tight relation among extracellular
Ca2, stc1, and trpv5/6 expression. Mus mutant embryos
experience Ca2 deficiency since there is no functional
trpv5/6, which is (insufficiently) counteracted by down-
regulation of the antihypercalcaemic hormone stc1.
The fact that the mutant phenotype is observed in
the vertebral column is most likely due to developmen-
tal timing: vertebrae are formed relatively late in devel-
opment. During early stages of development, there is
sufficient Ca2 present in the yolk (43), and embryos
can take up Ca2 in adequate amounts for initial
growth and survival (44). These sources suffice to allow
ossification in those structures that are first to ossify (3
dpf), like cleithrum and opercle. As development pro-
ceeds, there is an increasing need for Ca2 (43) and
trpv5/6-independent mechanisms are not able to supply
this amount. As a result, no bone is formed in struc-
tures that ossify later in development such as the tip of
the notochord and the vertebrae.
Our data show that mus mutants suffer from general
Ca2 deficiency. Arguments for this notion are as follows:
significantly reduced Ca2 content, loss of stc1 expression,
phenocopy in wild-type embryos by restricting Ca2 avail-
ability, and hypersensitivity to low Ca2 and rescue by
high Ca2. This phenotype strongly suggests the existence
of a hierarchy in the use of Ca2: the limited amount of
Ca2 that is present is used primarily to fulfill other
essential cell biological functions such as muscle contrac-
tion and secretion at the expense of bone formation.
Skeletal defects have been reported in zebrafish mu-
tants defective in other members of the TRP family. The
touchtone/nutria allele (trpm7) shows growth retardation
and alterations in skeletal development (45). In contrast,
trpm7 mutations and subsequent disturbance in Ca2 and
Mg2 homeostasis were found to be associated with
elevated levels of stc1 (46). This is probably due to residual
activity, since the allele is not a full loss of function. Further-
more, another TRP channel, TRPV4, has recently attracted
significant attention since it was linked to human bone
diseases (47, 48) and neurological disorders (49, 50).
Whereas mammalian TRPV5 and TRPV6 are very
similar in their biophysical properties, they differ sig-
nificantly in their sensitivity to block by RR, with IC50
values of 121 nM for TRPV5 compared with 9 M for
TRPV6 (51). We found that the RR sensitivity of
zebrafish Trpv5/6 is more comparable to that of mam-
malian TRPV6, with an IC50 value of 4 M. These
results, combined with phylogenetic analysis in ze-
brafish and pufferfish (52) and the absence of a second
isoform in fish, suggest that mammalian isoforms have
evolved separately from the other vertebrates and the
ancestral gene was duplicated after this event. The
ancestral isoform probably resembled TRPV6 most and
was duplicated as an adaptation to terrestrial life.
The mus phenotype is much more severe than the
phenotypes observed for knockouts of its murine coun-
terparts. Trpv5/ mice display reduced renal Ca2 reab-
sorption resulting in hypercalciuria and show only mild
disturbances in bone structures (26). Trpv5 was also
described as essential for osteoclast function (53). Trpv6-
deficient mice also show impaired Ca2 homeostasis
manifested as decreased intestinal Ca2 absorption, poor
weight gain, decreased bone mineral density, and re-
duced fertility (25). In addition, TRPV6 is involved in
maternal-fetal Ca2 transport (54). The mildness of phe-
Figure 6. Direct measurement of Ca2 influx. Cytosolic Ca2 measurements in HEK293 cells expressing Trpv5/6 (red trace) or
with no overexpression (black trace) using Fura-2. A) Representative experiment illustrating responses of cytosolic Ca2 on
addition of increasing concentrations of extracellular Ca2. B) Cytosolic responses of Trpv5/6-expressing cells (red bars) vs.
control cells (black bars) were quantified. Bars represent the average cytosolic response of 33 Trpv5/6-expressing cells and 27
control cells from 7 experiments. Values are depicted as average 
 se. *P	0.01; Student’s t test.
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notypes is best explained by redundancy and compensa-
tory mechanisms: in Trpv5-knockout mice, loss of Ca2 via
the urine is compensated by TRPV6-mediated Ca2 hy-
perabsorption in the intestine. On the other hand, Trpv5
up-regulation is not shown to occur in Trpv6-knockout
mice, although compensatory hypercalcemic PTH and
vitamin-D pathways are activated (25, 55). This indicates
that TRPV6 is not essential for intestinal Ca2 uptake,
unless Ca2 availability is restricted (56, 57). A double
knockout cannot be generated by crossing both strains,
since Trpv5 and Trpv6 are located adjacent to each other
on the same chromosome. Targeted inactivation of the
other known components of transcellular transport, Ncx1
and Pmca1, could not reveal their importance in transep-
ithelial Ca2 transport, since the respective knockout
mice are not viable (58, 59). Our study shows that if the
gatekeeper of the transcellular pathway is deficient, Ca2
cannot be transported adequately to sustain life. The
paracellular pathway or other processes cannot compen-
sate for the loss of this essential component. Zebrafish are
an attractive model for these studies since all molecular
components are conserved, but they contain only 1 gate-
keeper gene and have fewer compensatory mechanisms,
resulting in a fully informative loss-of-function phenotype.
In this study, we provide for the first time genetic and
functional evidence for an essential role of Trpv5/6 in
systemic Ca2 uptake and bone formation. We show that in
zebrafish, the transcellular uptake route for Ca2 in the gills
is the most important mechanism for Ca2 uptake, and
Trpv5/6 is a key molecular player in this process. Using
electrophysiological techniques and Ca2 imaging, we could
demonstrate that Trpv5/6 is a highly Ca2-selective channel
that allows Ca2 influx under physiological conditions.
In summary, this study shows for the first time an
animal model lacking active transepithelial Ca2 trans-
port, indicating the essential role of this process to
sustain life and enable bone formation. We further
show that Trpv5/6 is an essential molecular player in
this process. The mus zebrafish mutant line can there-
fore serve as an important screening tool for regulators
of transepithelial Ca2 uptake, bone density, and re-
lated disorders, such as osteoporosis.
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